Atlas Trials

High Dose Atorvastatin for Preventing Contrast-induced Nephropathy

Clinical trial NCT02114346 · COMPLETED

Trial details

NCT number
NCT02114346
Sponsor
Isfahan University of Medical Sciences
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Contrast-Induced Nephropathy
Start date
2013-07-01
Primary completion
2014-02-01
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.